Way back in 2012/13 after showing my wife the adapt platform she said it should be used for CABG( coronary artery bypass grafting) and it's taken a very long time to be developed to say the least . Better late than never.
The biggest move is still yet to be made. And that's to monetize the products to benefit its owners, us holders.
The master behind the adapt process is prof Neethling.
The remaining piece remains in the board monetizing it
Ann: Notice of Annual General Meeting/Proxy Form, page-15
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$11.50 |
Change
0.070(0.61%) |
Mkt cap ! $243.1M | |||
| Open | High | Low | Value | Volume |
| $11.45 | $11.50 | $11.32 | $90.21K | 7.885K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 53 | $11.26 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $11.50 | 2061 | 1 |
View Market Depth
| Last trade - 16.10pm 15/10/2024 (20 minute delay) ? |
| AVR (ASX) Chart |